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Abstract: 
RNA modifications have recently emerged as critical post-transcriptional regulators of gene 
expression programs. They impact diverse eukaryotic biological processes and the correct 
deposition of many of these modifications is required for normal development. Messenger RNA 
modifications regulate various aspects of mRNA metabolism. For example, N6-methyladenosine 
(m6A) affects the translation and stability of the modified transcripts, thus providing a 
mechanism to coordinate the regulation of groups of transcripts during cell state maintenance 
and transition. Similarly, some modifications in transfer RNAs are essential for RNA structure 
and function. Others are deposited in response to external cues and adapt global protein synthesis 
and gene-specific translational accordingly, and thereby facilitate proper development. 
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Main Text: 
Understanding normal tissue development and disease susceptibility requires knowledge of the 
various cellular mechanisms controlling gene expression in multicellular organisms. Much work 
has focused on investigating lineage-specific transcriptional networks governing stem cell 
differentiation [ref to other review articles in the special issue]. Yet, gene expression programs 
are dynamically regulated during development and require the coordination of both mRNA 
metabolism and protein synthesis. The deposition of chemical modifications onto RNA has 
emerged as a basic mechanism to modulate cellular transcriptomes and proteomes during lineage 
fate decision in development.  
 
Many of the over 170 modifications present in RNA have been known for decades, but only in 
the past several years have sufficiently sensitive tools and high-resolution genome-wide 
techniques been developed to identify and quantify these modifications in low abundance RNA 
species such as mRNA (1, 2). Some RNA modifications have been shown to affect normal 
development as certain modifications can control the turnover and translation of transcripts 
during cell state transitions and therefore, play important roles during tissue development and 
homeostasis. In particular, the N6-methyladenosine (m6A) modification of mRNA is an essential 
regulator of mammalian gene expression (3, 4). Other modifications such as 5-methylcytosine 
(m5C) and N1-methyladenosine (m1A) are currently best-described for their functional roles in 
non-coding RNAs but have also been studied in mRNA (3, 5).  
 
We summarize here recent studies that elucidate the roles of RNA modifications in modulating 
gene expression throughout cell differentiation and animal development. Due to space 
limitations, we will focus on m6A in mRNA and m5C in tRNA as notable examples. RNA editing 
and RNA tail modifications, which have been comprehensively reviewed previously, will not be 
included. 
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Types of RNA modifications  
 
Modifications in mRNA. In addition to the 5’ cap and 3’ polyadenylation, mRNAs contain 
numerous modified nucleosides, including base isomerization to produce pseudouridine (Ψ), 
methylation of the bases to produce m6A, m1A, and m5C, methylation of the ribose sugar to 
install 2’O-methylation (Nm, m6Am), and oxidation of m5C to 5-hydroxymethylcytosine (hm5C) 
(3). Of these, one of the most abundant and well-studied mRNA modifications is m6A. 20-40% 
of all transcripts encoded by mammalian cells are m6A methylated, and methylated mRNAs tend 
to contain multiple m6A per transcript (1, 2). m6A and other RNA modifications are also present 
in lncRNAs and miRNAs. 
 
The biological functions of m6A are mediated by writer, eraser, and reader proteins (Fig. 1A) (3). 
m6A is installed by a multi-protein writer complex consisting of the METTL3 catalytic subunit, 
and many other accessory subunits (3). Two demethylases, FTO and ALKBH5, act as erasers (6, 
7). m6A can both directly and indirectly affect the binding of reader proteins on methylated 
mRNAs (3). For example, YTHDF2 binds to m6A in mRNA and targets the transcripts for 
degradation (3, 8), and YTHDF1, YTHDF3 and eIF3a promote translation of m6A containing 
transcripts (3, 9, 10). The list of m6A readers regulating mRNA homeostasis is still growing (11, 
12), and the functions of m6A could depend on recognition by cell type-specific reader proteins. 
Reader and eraser proteins for other modifications are less well described.  
 
Modifications in tRNA and rRNA. In addition to mRNA, the faithful translation of the genetic 
code is orchestrated by at least two more types of RNAs, tRNA and rRNA. Human rRNAs 
contain a set of chemical modifications which often cluster at functionally important sites of the 
ribosome, such as the peptidyltransferase center and the decoding site (13). Modification in 
tRNAs are the most diverse, with cytoplasmic and mitochondrial tRNAs carrying over 100 
different modifications (Fig. 1B). A human tRNA can contain between 11 to 13 different 
modifications that are deposited at different steps during its maturation that could directly affect 
translation (14). The modifications range from simple methylation and isomerization events 
including m5C, m1A, Ψ, 5-methyluridine (m5U), 1- and 7-methylguanosine (m1G, m7G), and 
inosine to complex multiple step chemical modifications (Fig. 1B) (14). The function of a 
modification depends both on its location in the tRNA and its chemical nature. For example, 
m5C is site-specifically deposited by at least three enzymes NSUN2, NSUN3 and DNMT2 (Fig. 
1B) and all three enzymes influence tRNA metabolism differently. Modifications at the wobble 
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position are the most diverse and often optimize codon usage during gene-specific translation 
(Fig. 1B) (15, 16).  
 
RNA modifications in development 
 
mRNA modifications in development. A wealth of recent studies identified an essential role for 
m6A during development, and many of them highlighted a role for m6A in regulating 
transcriptome switching during embryonic and adult stem cell differentiation (3). An early clue 
that m6A is essential for development was the observation that removal of the m6A writer 
enzyme Mettl3 is embryonic lethal in mice (4). Mettl3-/- embryos appear normal pre-
implantation, but begin to show defects post-implantation and are absorbed by embryonic day 
8.5. Examination of gene expression from these embryos and depletion of Mettl3 in embryonic 
stem cells (ESCs) further suggested impaired exit from pluripotency as, for example, expression 
of the pluripotency factor Nanog was sustained (4, 17). Transcripts encoding certain pluripotency 
factors are methylated (4, 17, 18) which affects the turnover of these transcripts during 
differentiation. At least some of these transcripts are co-transcriptionally methylated through the 
recruitment of the m6A writer complex by cell-state specific transcription factors like Smad2 and 
Smad3 (19). Therefore, m6A marks transcripts encoding important developmental regulators to 
facilitate their turnover during cell fate transitions and thereby enables cells to properly switch 
their transcriptomes from one cellular state to another (Fig. 2A).  
 
This paradigm has also been used to explain the differentiation of other cell types. Conditional 
knockout of Mettl3 in CD4+ T-cells prevents the proliferation and differentiation of naïve T-cells 
through stabilization of Socs family genes (20). Loss of Mettl14 (an essential component of the 
METTL3/14 methyltransferase complex) in the brain delays cortical neurogenesis and is 
associated with slower cell cycle progression and impaired decay of transcripts involved in 
lineage specification of cortical neural stem cells (21). Similarly, deletion of Ythdf2 delays 
mouse neuronal development through impaired proliferation and differentiation of neural 
stem/progenitor cells (22). m6A-mediated RNA decay also regulates various stages of zebrafish 
development. For example, during the maternal-to-zygotic transition, embryos lacking Ythdf2 
exhibit impaired clearance of maternal transcripts, delaying embryonic development (23). Loss 
of Mettl3 blocks the endothelial-to-hematopoietic transition in zebrafish due to loss of the 
Ythdf2-mediated decay of genes that specify endothelial cell fate, such as Notch1a and Rhoca 
(24). 
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While these studies highlight the functional roles of the YTHDF2-mediated clearance of 
mRNAs, loss of Ythdf2 only partially accounts for phenotypes associated with loss of Mettl3. For 
example, loss of Mettl3 impairs priming of mammalian ESCs, yet Ythdf2 knockout embryos are 
able to exit pluripotency (22, 25). Similarly, Mettl3 deletion in zebrafish is lethal due to severe 
hematopoietic defects, but adult Ythdf2 knockout fish seem to be normal (23, 24). Work on 
gametogenesis highlights the importance of other m6A eraser and reader proteins in 
development, as loss of Mettl3, Mettl14, Alkbh5, Ythdf2, and Ythdc2 are all associated with 
impaired fertility and defects in spermatogenesis and/or oogenesis (7, 25-31). These defects were 
associated with the altered abundance, translation efficiency and splicing of methylated 
transcripts encoding regulators of gametogenesis. Work in Drosophila suggests important roles 
for m6A in mediating splicing as deletion of Ime4, the Mettl3 homolog, and other m6A writer 
complex subunits reduces viability of females due to inappropriate splicing of Sex lethal (Sxl), 
an important regulator of dosage compensation and sex determination (32, 33). 
 
Together, these studies demonstrate that the functional network coordinating mRNA methylation 
is highly complex and highlight the requirement of m6A for the proper execution of stem cell 
differentiation programs (Fig. 2A). Transcripts maintaining a cell state are most likely co-
transcriptionally decorated with m6A through the recruitment of the writer complex by cell-state 
specific transcription factors. While m6A promotes the decay of these transcripts, active 
transcription may maintain them at steady state levels with other readers potentially aiding in 
mediating their processing and translation. Upon receiving the signal(s) for cells to differentiate 
and repress transcription of these factors, m6A coordinates the timely decay of these transcripts, 
allowing cells to differentiate. While other posttranscriptional mechanisms aid in promoting cell 
state switching, the fact that m6A writers and readers are required for many of these transitions 
suggests that m6A regulates gene expression in ways that cannot be substituted by other similar 
mechanisms. 
 
tRNA modification in development. While RNA modifications are highly diverse and found in all 
RNA species, the recent discoveries underpin an emerging common theme: RNA modifications 
coordinate translation of transcripts encoding functionally related proteins when cells respond to 
differentiation or other cellular and environmental cues. Indeed, loss of tRNA modifying 
enzymes can delay stem cell differentiation, often only in distinct tissues. For instance, knockout 
of Nsun2 delays stem cell differentiation in brain and skin (34, 35). Depletion of Dnmt2 or the 
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pseudouridine synthase, Pus7, impairs hematopoietic stem cell commitment and delays 
endochondral ossification respectively (36, 37). Knockout of Elp3, a core component of 
Elongator that modifies the tRNA wobble position, is embryonic lethal (38).  
 
Several recent studies reveal that the dynamic deposition of tRNA modifications is a fast and 
efficient way for cells to adapt the protein translation machinery to external stimuli (37, 39-41). 
For example, self-renewing stem cells must be resilient to external differentiation cues and 
maintain protein synthesis at a low rate, yet their differentiation requires high levels of protein 
synthesis to produce committed progenitors. (39, 42, 43). The deposition of RNA modifications 
into tRNAs represents an efficient way to adapt energy requirements to specific cell states.  
 
Recent studies discovered that tRNA modifications regulate protein translation rates during 
development via tRNA-derived small non-coding RNA fragments (tRFs) (5, 37). Loss of 
NSUN2-mediated methylation at the variable loop increases the affinity to the endonuclease 
angiogenin, promotes cleavage of tRNAs into tRFs and inhibits global protein synthesis (34, 39). 
Similarly, the Ψ writer PUS7 modifies tRNAs and thereby influences the formation of tRFs 
which then target the translation initiation complex (37). Loss of DNMT2-mediated methylation 
at the anti-codon loop (C38) causes both tRNA-specific fragmentation and codon-specific 
mistranslation (36). Thus, altered tRNA modification patterns shape tRFs biogenesis and 
determine their intracellular abundances (Fig. 2B). tRFs could act on global and gene-specific 
protein translation by displacing distinct RNA binding proteins and are therefore important 
players in stem cell differentiation (37, 39), sperm maturation (44), retrotransposon silencing 
(45), intergenerational transmission of paternally acquired metabolic disorders (46), and breast 
cancer metastasis (47).  
 
Wobble tRNA modifications enhance the versatility of tRNA anti-codons to recognize mRNA to 
optimize codon usage and translation of cytoplasmic and mitochondrial mRNAs (Fig. 2B) (15, 
48-50). Mitochondria are crucial players in stem cell activation, fate decisions, tissue 
regeneration, aging and diseases (51). Mitochondrial translation can be affected by mitochondrial 
tRNA and mRNA modifications. Mammalian mitochondria use folate-bound one-carbon (1C) 
units to methylate tRNA through the serine hydroxymethyltransferase 2 (SHMT2). SHMT2 
provides methyl donors to produce the taurinomethyluridine base at the wobble position of 
distinct mitochondrial tRNAs. Loss of the catalytic activity of SHMT2 impairs OXPHOS and 
mitochondrial translation (52).  
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In summary, stem cell differentiation requires the constant and dynamic adaption of energy 
supply to fuel protein synthesis. A highly efficient and fast trigger to adapt global and gene-
specifc protein translation rates to external stimuli is the dynamic deposition, removal or 
oxidation of m5C to other forms of C in tRNAs.  
 
RNA modifications in disease 
 
tRNA modifications in disease. Complex human pathologies that are directly linked to tRNA 
modifications include cancer, type 2 diabetes, neurological disorders, and mitochondrial-linked 
disorders (53). The human brain is particular sensitive to defects in tRNA modifications (54), 
and the cellular defects are commonly caused by impaired translational efficiency and misfolded 
proteins leading to a deleterious activation of the cellular stress response.  
 
Similar to normal tissues, tumor cells are challenged by a changing micro-environment, for 
example through hypoxia, inflammatory cell infiltration and exposure to cytotoxic drug 
treatments (39). Thus, tumor cell populations rely on the correct deposition of tRNA 
modifications to switch their transcriptional and translation programs dynamically in response to 
external stimuli. For instance, skin tumors lacking the NSUN2-mediated m5C modification 
repress global protein synthesis leading to an enlarged undifferentiated tumour-initiating cell 
population (39). However, the up-regulation of NSUN2 and methylation of tRNAs is strictly 
required for cell survival in response to chemotherapeutic drug treatment, and NSUN2-negative 
tumors fail to regenerate after exposure to cytotoxic drug treatments (39). Thus, tumor-initiating 
cell populations require the tight control of protein synthesis for accurate cell responses and to 
maintain the bulk tumor. 
 
Similarly, modifications found in other non-coding RNAs are likely to play important roles in 
their biogenesis and function. For instance, the biogenesis of rRNA is known to be significantly 
affected by various modifications, the defect of which could contribute to human 
ribosomopathies (55).  
 
mRNA modifications in disease. mRNA modifications also contribute to the survival and growth 
of tumor cells, further highlighting the importance of mRNA modifications in regulating cell fate 
decisions. Both subunits of the m6A writer complex, METTL3 and METTL14 are highly 
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expressed in human hematopoietic stem and progenitor cells (HSPCs) and the expression of 
these two subunits declines during differentiation of HSPCs along the myeloid lineage (56, 57). 
Over-expression of METTL3 inhibits cell differentiation and increases cell growth (56, 57). 
Consistent with a role in maintaining self-renewal programs, METTL3 and METTL14 are 
overexpressed in acute myeloiod leukemia (AML) and AML cells are sensitive to depletion of 
METTL3 and METTL14 (56-58). These effects could be mediated by changes in the methylation 
of cell-state specific transcripts such as MYC, MYB, BCL2, PTEN, and SP1 that help to maintain 
self-renewal and prevent differentiation (56-58). Interestingly, the stabilization of certain m6A 
methylated transcripts in AML cells may be mediated by the IGF2BP1-3 family of m6A reader 
proteins rather than the YTHDF1-3 family (12, 57).  
 
An opposite role for m6A in leukemogenesis was found in certain subtypes of AML with 
increased expression of the demethylase FTO, resulting in decreased m6A and elevated levels of 
oncogene transcripts (59). Inhibition of FTO reduces AML cell proliferation and viability in 
these cell types (59, 60). The mechanisms and pathways for the writers and eraser to impact 
AML are likely distinct. While elevated writers block differentiation of HPSCs contributing to 
AML initiation and cell survival, elevated FTO mostly impacts AML proliferation. This 
distinction is exemplified by the dual role of the oncometabolite R-2HG; its inhibition of TET2 
contributes to AML initiation but also inhibits FTO in a subset of AML leading to repressed 
proliferation (60). Decreased m6A is also associated with some solid tumors, likely promoting 
their proliferation. For example, in breast cancer, hypoxia was shown to induce the 
overexpression of ALKBH5, an m6A eraser, and ZNF217, a transcription factor that can inhibit 
METTL3, resulting in reduction of the m6A methylation and decay of transcripts like Nanog (61, 
62). Similarly, overexpression of ALKBH5 or downregulation of METTL3 or METTL14 
promotes the tumorigenicity of glioblastoma cells through stabilization of pro-proliferative 
transcripts like FOXM1 (63, 64). Additional mechanisms for how m6A alters gene expression to 
help drive cancer progression are likely to be discovered in the future. 
 
Future perspectives  
 
While these studies demonstrate the roles of RNA modifications in various developmental 
processes, our understanding of how RNA modifications contribute to these processes remains 
incomplete, especially at the mechanistic level (Fig. 3).  The development of new tools that can 
determine the transcriptome-wide distribution of RNA modifications at nucleotide resolution 
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with quantitative information about the modification fraction would greatly help in these 
endeavors. Further, it will be essential to understand the intrinsic and extrinsic factors 
determining the specificity of the RNA modification writers, readers and erasers, and how these 
proteins are regulated in different cell types across development. For many RNA modifications, 
there is only very little information available on how other RNA modifications recruit or repel 
RNA-binding proteins, yet this information is essential for understanding how RNA 
modifications modulate the RNA processing or protein translation machineries. In addition, how 
cells adjust RNA modifications and adapt the protein synthesis machinery in response to 
metabolic requirements remains largely unclear, in particular, how these changes in translation 
could have cell-type specific effects. Finally, recent studies have suggested that m6A could 
directly or indirectly influence chromatin state and transcription through regulation of chromatin 
regulatory complexes and lncRNAs (65, 66). The potential roles of m6A and other RNA 
modifications in shaping chromatin states may provide additional mechanisms for explaining 
how these modifications contribute to gene regulation in development. 
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Figures: 
 
Figure 1. Regulation of gene expression by RNA modifications. (a) m6A is installed by a 
multicomponent writer complex with the catalytic subunit METTL3 and removed by the 
demethylase enzymes FTO and ALKBH5. m6A reader proteins can specifically bind m6A 
transcripts and effect different outcomes for methylated mRNAs. (b) RNA modifications in 
human eukaryotic tRNAs according to Modomics 
(http://genesilico.pl/trnamodviz/jit_viz/select_tRNA/). xU: other modified uracil (U). N: 
unknown modified. How often a base is modified is shown by the greyscale. Only examples of 
writers (TRM6/61, DNMT2, NSUN2, NSUN3, PUS7 and Elongator) and erasers (ALKBH1) are 
shown and how they affect translation. Modifications at the wobble base are most diverse.  
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Fig. 2. RNA modifications regulate cell differentiation and development. (a) Model for the 
roles of m6A in cell differentiation. In the naïve, undifferentiated state, cell-state specific master 
transcription factors recruit the METTL3 complex to methylate transcripts encoding cell fate 
factors. Translation of these methylated factors may aid in the maintenance of cell state and 
prevent differentiation. When cells initiate differentiation and switch their transcriptional 
program, reader proteins mediate the turnover of the methylated transcripts to facilitate 
transcriptome switching. (b) Modification by NSUN2, DNMT2 and PUS7 protects tRNAs from 
cleavage and production of tRFs, which enables high global translation. In a different cell state, 
tRFs can affect global and gene-specific protein translation by displacing distinct RNA binding 
proteins (RBP) and are therefore important players in stem cell differentiation. Wobble tRNA 
modifications, for example by NSUN3 and Elongator, enhance the versatility of tRNA anti-
codon to recognize mRNA to optimize codon usage and translation of cytoplasmic and 
mitochondrial mRNAs during differentiation.  
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Fig. 3. Future directions for research into gene regulation by RNA modifications. 
Unresolved questions in the field include: Mechanistically, how do external stimuli regulate 
RNA modification to affect protein translation rates and transcription? How do RNA modifying 
enzymes act as metabolic sensors? How do RNA modifications directly or indirectly regulate 
chromatin regulatory complexes to affect chromatin state or transcription? What factors, such as 
transcription factors, chromatin, RNA, RNA binding proteins or components of the RNA 
polymerase II complex, recruit m6A writer and eraser enzymes to their targets? How are the 
protein synthesis and transcription machineries coordinated by RNA modifications?  
